Enanta Pharmaceuticals News

Hold Rating on Enanta Pharmaceuticals Amidst Clinical Trials Uncertainty and Financial Outlook

TipRanksMay 8 11:58

Buy Rating Affirmed for Enanta Pharmaceuticals Amidst Promising RSV Developments and Clinical Trial Execution

TipRanksMay 7 23:35

J.P. Morgan Securities: Maintaining the Enanta Pharma (ENTA.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $23.00 to $22.00.

Zhitong FinanceMay 7 23:40

Enanta Pharma Analyst Ratings

BenzingaMay 7 23:32

JMP Securities Maintains Market Outperform on Enanta Pharma, Lowers Price Target to $22

BenzingaMay 7 23:34

Analysts' Top Healthcare Picks: OrthoPediatrics (KIDS), Enanta Pharmaceuticals (ENTA)

TipRanksMay 7 13:01

Analysts' Opinions Are Mixed on These Healthcare Stocks: Enanta Pharmaceuticals (ENTA), OrthoPediatrics (KIDS) and Avanos Medical (AVNS)

TipRanksMay 7 12:51

Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating

MT NewswiresFeb 9 22:00

Oppenheimer Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA)

TipRanksFeb 9 20:58

Maintaining Hold on Enanta Pharmaceuticals Amid Near-Term Challenges and Pipeline Potential

TipRanksFeb 9 13:51

Enanta Pharma Analyst Ratings

BenzingaFeb 9 05:42

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)

TipRanksFeb 8 21:10

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Enanta Pharmaceuticals (ENTA) and Steris (STE)

TipRanksFeb 8 13:30

Analysts Are Bullish on These Healthcare Stocks: Enanta Pharmaceuticals (ENTA), Spruce Biosciences (SPRB)

TipRanksJan 9 14:21

Analysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), Enanta Pharmaceuticals (ENTA) and Synlogic (SYBX)

TipRanksJan 9 14:01

Analysts Are Bullish on These Healthcare Stocks: Black Diamond Therapeutics (BDTX), Enanta Pharmaceuticals (ENTA)

TipRanksJan 5 19:30

Buy Rating on Enanta Pharmaceuticals Amidst Promising RSV Program Developments and Strategic Expansion Into CSU Market

TipRanksJan 5 03:35

Enanta Pharma Analyst Ratings

BenzingaNov 23, 2023 02:46

Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $21 From $25, Maintains Perform Rating

MT NewswiresNov 22, 2023 22:43

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Enanta Pharmaceuticals (ENTA) and Arvinas Holding Company (ARVN)

TipRanksNov 22, 2023 20:20